Stay updated with breaking news from Cold Syrup. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Central Government on Wednesday formed a four-member expert committee to investigate the report sent by the World Health Organisation (WHO) on the deaths of
The suspension of membership implies that Maiden Pharmaceuticals will not be eligible to receive any incentives.
Central Drugs Standard Control Organisation (CDSCO) launched an inquiry and alerted Haryana last week after learning about the Gambia tragedy.
After the World Health Organization (WHO) warned that it suspected four cough syrups could be linked to the deaths of 66 children in Gambia, the Delhi-based manufacturer, Maiden Pharmaceuticals, is in the news. The syrups, the WHO said, have been “potentially linked with acute kidney injuries and 66 deaths among children.” The global body also
Following the WHO’s warning, the centre is looking into four cough syrups that may be responsible for at least 66 child deaths in The Gambia. India has already been under fire for exporting fake and substandard medications, but it also has a similar issue at home. Indian-made cough syrups are being investigated in connection with